ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rheumatology Drugs Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-29B5986
Home | Market Reports | Health| Health Conditions| Arthritis
Global Rheumatology Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Rheumatology Drugs Market Research Report 2024

Code: QYRE-Auto-29B5986
Report
February 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda Pharmaceutical
Sanofi
Genentech Inc
Novartis
Janssen Biotech
Amgen Inc
AbbVie
Pfizer Inc
Bristol Myers Squibb Company
Merck

Rheumatology Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rheumatology Drugs Market

Rheumatology Drugs Market

The global Rheumatology Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rheumatology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Drugs.

Report Scope

The Rheumatology Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rheumatology Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatology Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rheumatology Drugs Market Report

Report Metric Details
Report Name Rheumatology Drugs Market
CAGR 5%
Segment by Type
  • Disease Modifying Anti-rheumatic Drugs
  • Nonsteroidal Anti-inflammatory Drugs
  • Corticosteroids
  • Uric Acid Drugs
  • Others
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rheumatology Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rheumatology Drugs Market report?

Ans: The main players in the Rheumatology Drugs Market are Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer, Bristol-Myers Squibb Company, Merck & Co.

What are the Application segmentation covered in the Rheumatology Drugs Market report?

Ans: The Applications covered in the Rheumatology Drugs Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Rheumatology Drugs Market report?

Ans: The Types covered in the Rheumatology Drugs Market report are Disease Modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Disease Modifying Anti-rheumatic Drugs
1.2.3 Nonsteroidal Anti-inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Uric Acid Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rheumatology Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatology Drugs Market Perspective (2019-2030)
2.2 Rheumatology Drugs Growth Trends by Region
2.2.1 Global Rheumatology Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rheumatology Drugs Historic Market Size by Region (2019-2024)
2.2.3 Rheumatology Drugs Forecasted Market Size by Region (2025-2030)
2.3 Rheumatology Drugs Market Dynamics
2.3.1 Rheumatology Drugs Industry Trends
2.3.2 Rheumatology Drugs Market Drivers
2.3.3 Rheumatology Drugs Market Challenges
2.3.4 Rheumatology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatology Drugs Players by Revenue
3.1.1 Global Top Rheumatology Drugs Players by Revenue (2019-2024)
3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatology Drugs Revenue
3.4 Global Rheumatology Drugs Market Concentration Ratio
3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2023
3.5 Rheumatology Drugs Key Players Head office and Area Served
3.6 Key Players Rheumatology Drugs Product Solution and Service
3.7 Date of Enter into Rheumatology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatology Drugs Breakdown Data by Type
4.1 Global Rheumatology Drugs Historic Market Size by Type (2019-2024)
4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2025-2030)
5 Rheumatology Drugs Breakdown Data by Application
5.1 Global Rheumatology Drugs Historic Market Size by Application (2019-2024)
5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rheumatology Drugs Market Size (2019-2030)
6.2 North America Rheumatology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rheumatology Drugs Market Size by Country (2019-2024)
6.4 North America Rheumatology Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rheumatology Drugs Market Size (2019-2030)
7.2 Europe Rheumatology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rheumatology Drugs Market Size by Country (2019-2024)
7.4 Europe Rheumatology Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatology Drugs Market Size (2019-2030)
8.2 Asia-Pacific Rheumatology Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rheumatology Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Rheumatology Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rheumatology Drugs Market Size (2019-2030)
9.2 Latin America Rheumatology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rheumatology Drugs Market Size by Country (2019-2024)
9.4 Latin America Rheumatology Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatology Drugs Market Size (2019-2030)
10.2 Middle East & Africa Rheumatology Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rheumatology Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Rheumatology Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2019-2024)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rheumatology Drugs Introduction
11.2.4 Sanofi Revenue in Rheumatology Drugs Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Genentech
11.3.1 Genentech Company Detail
11.3.2 Genentech Business Overview
11.3.3 Genentech Rheumatology Drugs Introduction
11.3.4 Genentech Revenue in Rheumatology Drugs Business (2019-2024)
11.3.5 Genentech Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Rheumatology Drugs Introduction
11.4.4 Novartis Revenue in Rheumatology Drugs Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Rheumatology Drugs Introduction
11.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2019-2024)
11.5.5 Janssen Biotech Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Rheumatology Drugs Introduction
11.6.4 Amgen Revenue in Rheumatology Drugs Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Rheumatology Drugs Introduction
11.7.4 AbbVie Revenue in Rheumatology Drugs Business (2019-2024)
11.7.5 AbbVie Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Rheumatology Drugs Introduction
11.8.4 Pfizer Revenue in Rheumatology Drugs Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Detail
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2019-2024)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Detail
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Rheumatology Drugs Introduction
11.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2019-2024)
11.10.5 Merck & Co. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Takeda Pharmaceutical
Sanofi
Genentech Inc
Novartis
Janssen Biotech
Amgen Inc
AbbVie
Pfizer Inc
Bristol Myers Squibb Company
Merck
List of Tables
    Table 1. Global Rheumatology Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs
    Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Uric Acid Drugs
    Table 6. Key Players of Others
    Table 7. Global Rheumatology Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Rheumatology Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Rheumatology Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Rheumatology Drugs Market Share by Region (2019-2024)
    Table 11. Global Rheumatology Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Rheumatology Drugs Market Share by Region (2025-2030)
    Table 13. Rheumatology Drugs Market Trends
    Table 14. Rheumatology Drugs Market Drivers
    Table 15. Rheumatology Drugs Market Challenges
    Table 16. Rheumatology Drugs Market Restraints
    Table 17. Global Rheumatology Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Rheumatology Drugs Market Share by Players (2019-2024)
    Table 19. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2023)
    Table 20. Ranking of Global Top Rheumatology Drugs Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Rheumatology Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Rheumatology Drugs Product Solution and Service
    Table 24. Date of Enter into Rheumatology Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Rheumatology Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Rheumatology Drugs Revenue Market Share by Type (2019-2024)
    Table 28. Global Rheumatology Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Rheumatology Drugs Revenue Market Share by Type (2025-2030)
    Table 30. Global Rheumatology Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Rheumatology Drugs Revenue Market Share by Application (2019-2024)
    Table 32. Global Rheumatology Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Rheumatology Drugs Revenue Market Share by Application (2025-2030)
    Table 34. North America Rheumatology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Rheumatology Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Rheumatology Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Rheumatology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Rheumatology Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Rheumatology Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Rheumatology Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Rheumatology Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Rheumatology Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Rheumatology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Rheumatology Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Rheumatology Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Rheumatology Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Rheumatology Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Rheumatology Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Takeda Pharmaceutical Company Detail
    Table 50. Takeda Pharmaceutical Business Overview
    Table 51. Takeda Pharmaceutical Rheumatology Drugs Product
    Table 52. Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 53. Takeda Pharmaceutical Recent Development
    Table 54. Sanofi Company Detail
    Table 55. Sanofi Business Overview
    Table 56. Sanofi Rheumatology Drugs Product
    Table 57. Sanofi Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 58. Sanofi Recent Development
    Table 59. Genentech Company Detail
    Table 60. Genentech Business Overview
    Table 61. Genentech Rheumatology Drugs Product
    Table 62. Genentech Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 63. Genentech Recent Development
    Table 64. Novartis Company Detail
    Table 65. Novartis Business Overview
    Table 66. Novartis Rheumatology Drugs Product
    Table 67. Novartis Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 68. Novartis Recent Development
    Table 69. Janssen Biotech Company Detail
    Table 70. Janssen Biotech Business Overview
    Table 71. Janssen Biotech Rheumatology Drugs Product
    Table 72. Janssen Biotech Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 73. Janssen Biotech Recent Development
    Table 74. Amgen Company Detail
    Table 75. Amgen Business Overview
    Table 76. Amgen Rheumatology Drugs Product
    Table 77. Amgen Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 78. Amgen Recent Development
    Table 79. AbbVie Company Detail
    Table 80. AbbVie Business Overview
    Table 81. AbbVie Rheumatology Drugs Product
    Table 82. AbbVie Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 83. AbbVie Recent Development
    Table 84. Pfizer Company Detail
    Table 85. Pfizer Business Overview
    Table 86. Pfizer Rheumatology Drugs Product
    Table 87. Pfizer Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 88. Pfizer Recent Development
    Table 89. Bristol-Myers Squibb Company Company Detail
    Table 90. Bristol-Myers Squibb Company Business Overview
    Table 91. Bristol-Myers Squibb Company Rheumatology Drugs Product
    Table 92. Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 93. Bristol-Myers Squibb Company Recent Development
    Table 94. Merck & Co. Company Detail
    Table 95. Merck & Co. Business Overview
    Table 96. Merck & Co. Rheumatology Drugs Product
    Table 97. Merck & Co. Revenue in Rheumatology Drugs Business (2019-2024) & (US$ Million)
    Table 98. Merck & Co. Recent Development
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rheumatology Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Rheumatology Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Disease Modifying Anti-rheumatic Drugs Features
    Figure 4. Nonsteroidal Anti-inflammatory Drugs Features
    Figure 5. Corticosteroids Features
    Figure 6. Uric Acid Drugs Features
    Figure 7. Others Features
    Figure 8. Global Rheumatology Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Rheumatology Drugs Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Pharmacy Case Studies
    Figure 11. Retail Pharmacy Case Studies
    Figure 12. Online Pharmacy Case Studies
    Figure 13. Rheumatology Drugs Report Years Considered
    Figure 14. Global Rheumatology Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Rheumatology Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Rheumatology Drugs Market Share by Region: 2023 VS 2030
    Figure 17. Global Rheumatology Drugs Market Share by Players in 2023
    Figure 18. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Rheumatology Drugs Revenue in 2023
    Figure 20. North America Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Rheumatology Drugs Market Share by Country (2019-2030)
    Figure 22. United States Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Rheumatology Drugs Market Share by Country (2019-2030)
    Figure 26. Germany Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Rheumatology Drugs Market Share by Region (2019-2030)
    Figure 34. China Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Rheumatology Drugs Market Share by Country (2019-2030)
    Figure 42. Mexico Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Rheumatology Drugs Market Share by Country (2019-2030)
    Figure 46. Turkey Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Rheumatology Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 49. Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 50. Genentech Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 51. Novartis Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 52. Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 53. Amgen Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 54. AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 55. Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 56. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 57. Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2019-2024)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Osteoarthritis Pain Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6Z3154
Fri Mar 15 00:00:00 UTC 2024

Add to Cart

Global Osteoarthritis Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31R1606
Fri Mar 15 00:00:00 UTC 2024

Add to Cart

Global Osteoarthritis Medications Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-28E5704
Tue Mar 12 00:00:00 UTC 2024

Add to Cart

Global Juvenile Idiopathic Arthritis Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-21W1178
Tue Mar 05 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions